vs

Side-by-side financial comparison of ECB Bancorp, Inc. (ECBK) and Lakeside Holding Ltd (LSH). Click either name above to swap in a different company.

ECB Bancorp, Inc. is the larger business by last-quarter revenue ($9.5M vs $7.0M, roughly 1.4× Lakeside Holding Ltd). ECB Bancorp, Inc. runs the higher net margin — 27.3% vs -22.6%, a 49.9% gap on every dollar of revenue. On growth, Lakeside Holding Ltd posted the faster year-over-year revenue change (95.0% vs 33.8%).

ECB Bancorp, Inc. (MD) is a US-based bank holding company. It offers a full suite of retail and commercial banking products including deposit accounts, consumer loans, commercial financing and wealth management solutions, primarily serving individuals and small-to-mid enterprises across local markets in Maryland.

Lakeside Press was a Chicago publishing imprint under which the RR Donnelley Company produced fine books as well as mail order catalogs, telephone directories, encyclopedias, and advertising. The Press was best known for its high quality editions for the Chicago Caxton Club as well as the Lakeside Classics, a series of fine reprints.

ECBK vs LSH — Head-to-Head

Bigger by revenue
ECBK
ECBK
1.4× larger
ECBK
$9.5M
$7.0M
LSH
Growing faster (revenue YoY)
LSH
LSH
+61.2% gap
LSH
95.0%
33.8%
ECBK
Higher net margin
ECBK
ECBK
49.9% more per $
ECBK
27.3%
-22.6%
LSH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ECBK
ECBK
LSH
LSH
Revenue
$9.5M
$7.0M
Net Profit
$2.6M
$-1.6M
Gross Margin
27.2%
Operating Margin
36.7%
-21.3%
Net Margin
27.3%
-22.6%
Revenue YoY
33.8%
95.0%
Net Profit YoY
79.5%
18.7%
EPS (diluted)
$0.32
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECBK
ECBK
LSH
LSH
Q4 25
$9.5M
$7.0M
Q3 25
$8.8M
$6.1M
Q2 25
$8.0M
$6.3M
Q1 25
$6.9M
$3.8M
Q4 24
$7.1M
$3.6M
Q3 24
$6.6M
$4.1M
Q2 24
$6.3M
Q1 24
$6.2M
Net Profit
ECBK
ECBK
LSH
LSH
Q4 25
$2.6M
$-1.6M
Q3 25
$2.4M
$-1.4M
Q2 25
$1.4M
$-893.1K
Q1 25
$1.3M
$-1.1M
Q4 24
$1.4M
$-1.9M
Q3 24
$1.1M
$-1.3M
Q2 24
$791.0K
Q1 24
$621.0K
Gross Margin
ECBK
ECBK
LSH
LSH
Q4 25
27.2%
Q3 25
18.2%
Q2 25
26.7%
Q1 25
18.8%
Q4 24
-1.2%
Q3 24
12.8%
Q2 24
Q1 24
Operating Margin
ECBK
ECBK
LSH
LSH
Q4 25
36.7%
-21.3%
Q3 25
37.0%
-20.8%
Q2 25
23.9%
-8.9%
Q1 25
24.9%
-28.2%
Q4 24
27.3%
-55.6%
Q3 24
23.3%
-32.5%
Q2 24
16.9%
Q1 24
13.4%
Net Margin
ECBK
ECBK
LSH
LSH
Q4 25
27.3%
-22.6%
Q3 25
27.7%
-22.2%
Q2 25
18.0%
-14.2%
Q1 25
18.7%
-28.2%
Q4 24
20.3%
-54.1%
Q3 24
17.2%
-32.7%
Q2 24
12.6%
Q1 24
10.0%
EPS (diluted)
ECBK
ECBK
LSH
LSH
Q4 25
$0.32
$-0.08
Q3 25
$0.29
$-0.09
Q2 25
$0.17
$-0.11
Q1 25
$0.16
$-0.14
Q4 24
$0.18
$-0.26
Q3 24
$0.14
$-0.18
Q2 24
$0.09
Q1 24
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECBK
ECBK
LSH
LSH
Cash + ST InvestmentsLiquidity on hand
$82.8M
$1.6M
Total DebtLower is stronger
$2.4M
Stockholders' EquityBook value
$171.9M
$12.2M
Total Assets
$1.6B
$24.3M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECBK
ECBK
LSH
LSH
Q4 25
$82.8M
$1.6M
Q3 25
$201.9M
$4.5M
Q2 25
$191.0M
$5.0M
Q1 25
$143.7M
$1.5M
Q4 24
$309.4M
$1.1M
Q3 24
$114.8M
$2.7M
Q2 24
$108.7M
Q1 24
$109.8M
Total Debt
ECBK
ECBK
LSH
LSH
Q4 25
$2.4M
Q3 25
$2.4M
Q2 25
$1.4M
Q1 25
$774.2K
Q4 24
$784.8K
Q3 24
$589.9K
Q2 24
Q1 24
Stockholders' Equity
ECBK
ECBK
LSH
LSH
Q4 25
$171.9M
$12.2M
Q3 25
$169.3M
$7.0M
Q2 25
$168.3M
$2.8M
Q1 25
$168.6M
$749.8K
Q4 24
$168.3M
$1.6M
Q3 24
$166.0M
$3.6M
Q2 24
$166.5M
Q1 24
$165.8M
Total Assets
ECBK
ECBK
LSH
LSH
Q4 25
$1.6B
$24.3M
Q3 25
$1.6B
$18.6M
Q2 25
$1.5B
$14.4M
Q1 25
$1.5B
$9.9M
Q4 24
$1.4B
$9.8M
Q3 24
$1.4B
$10.8M
Q2 24
$1.3B
Q1 24
$1.3B
Debt / Equity
ECBK
ECBK
LSH
LSH
Q4 25
0.20×
Q3 25
0.35×
Q2 25
0.48×
Q1 25
1.03×
Q4 24
0.48×
Q3 24
0.16×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECBK
ECBK
LSH
LSH
Operating Cash FlowLast quarter
$9.2M
$-453.5K
Free Cash FlowOCF − Capex
$9.0M
FCF MarginFCF / Revenue
94.7%
Capex IntensityCapex / Revenue
2.2%
Cash ConversionOCF / Net Profit
3.55×
TTM Free Cash FlowTrailing 4 quarters
$14.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECBK
ECBK
LSH
LSH
Q4 25
$9.2M
$-453.5K
Q3 25
$4.0M
$-4.0M
Q2 25
$1.9M
$-483.7K
Q1 25
$-631.0K
$-238.3K
Q4 24
$6.2M
$-530.2K
Q3 24
$861.0K
$-1.4M
Q2 24
$1.4M
Q1 24
$-429.0K
Free Cash Flow
ECBK
ECBK
LSH
LSH
Q4 25
$9.0M
Q3 25
$4.0M
Q2 25
$1.8M
$-497.4K
Q1 25
$-649.0K
Q4 24
$6.2M
$-560.5K
Q3 24
$-1.4M
Q2 24
$1.3M
Q1 24
$-449.0K
FCF Margin
ECBK
ECBK
LSH
LSH
Q4 25
94.7%
Q3 25
44.9%
Q2 25
23.0%
-7.9%
Q1 25
-9.4%
Q4 24
86.8%
-15.6%
Q3 24
-34.5%
Q2 24
21.4%
Q1 24
-7.2%
Capex Intensity
ECBK
ECBK
LSH
LSH
Q4 25
2.2%
Q3 25
0.8%
Q2 25
0.6%
0.2%
Q1 25
0.3%
0.0%
Q4 24
0.8%
0.8%
Q3 24
0.0%
0.1%
Q2 24
0.6%
Q1 24
0.3%
Cash Conversion
ECBK
ECBK
LSH
LSH
Q4 25
3.55×
Q3 25
1.65×
Q2 25
1.32×
Q1 25
-0.49×
Q4 24
4.31×
Q3 24
0.76×
Q2 24
1.75×
Q1 24
-0.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ECBK
ECBK

Segment breakdown not available.

LSH
LSH

Transferred Over Time$4.6M65%
Distribution Of Pharmaceutical Products$2.4M35%

Related Comparisons